▶ 調査レポート

ヒトパピローマウイルス(HPV)治療薬の世界市場(~2026年)

• 英文タイトル:Global Human Papillomaviru Therapeutics Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ヒトパピローマウイルス(HPV)治療薬の世界市場(~2026年) / Global Human Papillomaviru Therapeutics Market Size, Status and Forecast 2020-2026 / MRC2-11QY12256資料のイメージです。• レポートコード:MRC2-11QY12256
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、93ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はヒトパピローマウイルス(HPV)治療薬のグローバル市場について調査・分析したレポートです。種類別(免疫調節剤、角質溶解剤、抗腫瘍剤、シネカテキン)市場規模、用途別(生殖器疣贅、生殖器癌、疣冗長表皮異形成症、口腔乳頭腫、中咽頭癌、喉頭乳頭腫症、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ヒトパピローマウイルス(HPV)治療薬の競争状況、市場シェア
・世界のヒトパピローマウイルス(HPV)治療薬市場:種類別市場規模 2015年-2020年(免疫調節剤、角質溶解剤、抗腫瘍剤、シネカテキン)
・世界のヒトパピローマウイルス(HPV)治療薬市場:種類別市場規模予測 2021年-2026年(免疫調節剤、角質溶解剤、抗腫瘍剤、シネカテキン)
・世界のヒトパピローマウイルス(HPV)治療薬市場:用途別市場規模 2015年-2020年(生殖器疣贅、生殖器癌、疣冗長表皮異形成症、口腔乳頭腫、中咽頭癌、喉頭乳頭腫症、その他)
・世界のヒトパピローマウイルス(HPV)治療薬市場:用途別市場規模予測 2021年-2026年(生殖器疣贅、生殖器癌、疣冗長表皮異形成症、口腔乳頭腫、中咽頭癌、喉頭乳頭腫症、その他)
・北米のヒトパピローマウイルス(HPV)治療薬市場分析:米国、カナダ
・ヨーロッパのヒトパピローマウイルス(HPV)治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのヒトパピローマウイルス(HPV)治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のヒトパピローマウイルス(HPV)治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのヒトパピローマウイルス(HPV)治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AbbVie、Actavis、Clinigen Group、Merck、Perrigo Company、Roche、Bausch Health
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Human Papillomaviru Therapeutics Market
The global Human Papillomaviru Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Human Papillomaviru Therapeutics Scope and Market Size
Human Papillomaviru Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Papillomaviru Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
AbbVie
Actavis
Clinigen Group
Merck
Perrigo Company
Roche
Bausch Health

Market segment by Type, the product can be split into
Immunomodulators
Keratolytic Agents
Anti-neoplastic Agents
Sinecatechins
Market segment by Application, split into
Genital Warts
Genital Cancer
Epidermodysplasia Verruciformis
Oral Papillomas
Oropharyngeal Cancer
Laryngeal Papillomatosis
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Papillomaviru Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Human Papillomaviru Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunomodulators
1.4.3 Keratolytic Agents
1.4.4 Anti-neoplastic Agents
1.4.5 Sinecatechins
1.5 Market by Application
1.5.1 Global Human Papillomaviru Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Genital Warts
1.5.3 Genital Cancer
1.5.4 Epidermodysplasia Verruciformis
1.5.5 Oral Papillomas
1.5.6 Oropharyngeal Cancer
1.5.7 Laryngeal Papillomatosis
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Human Papillomaviru Therapeutics Market Perspective (2015-2026)
2.2 Global Human Papillomaviru Therapeutics Growth Trends by Regions
2.2.1 Human Papillomaviru Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Papillomaviru Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Human Papillomaviru Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Human Papillomaviru Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Human Papillomaviru Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Human Papillomaviru Therapeutics Players by Market Size
3.1.1 Global Top Human Papillomaviru Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Human Papillomaviru Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Papillomaviru Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Papillomaviru Therapeutics Market Concentration Ratio
3.2.1 Global Human Papillomaviru Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Papillomaviru Therapeutics Revenue in 2019
3.3 Human Papillomaviru Therapeutics Key Players Head office and Area Served
3.4 Key Players Human Papillomaviru Therapeutics Product Solution and Service
3.5 Date of Enter into Human Papillomaviru Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Human Papillomaviru Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Human Papillomaviru Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Human Papillomaviru Therapeutics Market Size by Application (2015-2020)
5.2 Global Human Papillomaviru Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Human Papillomaviru Therapeutics Market Size (2015-2020)
6.2 Human Papillomaviru Therapeutics Key Players in North America (2019-2020)
6.3 North America Human Papillomaviru Therapeutics Market Size by Type (2015-2020)
6.4 North America Human Papillomaviru Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Human Papillomaviru Therapeutics Market Size (2015-2020)
7.2 Human Papillomaviru Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Human Papillomaviru Therapeutics Market Size by Type (2015-2020)
7.4 Europe Human Papillomaviru Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Human Papillomaviru Therapeutics Market Size (2015-2020)
8.2 Human Papillomaviru Therapeutics Key Players in China (2019-2020)
8.3 China Human Papillomaviru Therapeutics Market Size by Type (2015-2020)
8.4 China Human Papillomaviru Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Human Papillomaviru Therapeutics Market Size (2015-2020)
9.2 Human Papillomaviru Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Human Papillomaviru Therapeutics Market Size by Type (2015-2020)
9.4 Japan Human Papillomaviru Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Human Papillomaviru Therapeutics Market Size (2015-2020)
10.2 Human Papillomaviru Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Papillomaviru Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Human Papillomaviru Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Human Papillomaviru Therapeutics Market Size (2015-2020)
11.2 Human Papillomaviru Therapeutics Key Players in India (2019-2020)
11.3 India Human Papillomaviru Therapeutics Market Size by Type (2015-2020)
11.4 India Human Papillomaviru Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Human Papillomaviru Therapeutics Market Size (2015-2020)
12.2 Human Papillomaviru Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Papillomaviru Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Human Papillomaviru Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Human Papillomaviru Therapeutics Introduction
13.1.4 AbbVie Revenue in Human Papillomaviru Therapeutics Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Actavis
13.2.1 Actavis Company Details
13.2.2 Actavis Business Overview
13.2.3 Actavis Human Papillomaviru Therapeutics Introduction
13.2.4 Actavis Revenue in Human Papillomaviru Therapeutics Business (2015-2020)
13.2.5 Actavis Recent Development
13.3 Clinigen Group
13.3.1 Clinigen Group Company Details
13.3.2 Clinigen Group Business Overview
13.3.3 Clinigen Group Human Papillomaviru Therapeutics Introduction
13.3.4 Clinigen Group Revenue in Human Papillomaviru Therapeutics Business (2015-2020)
13.3.5 Clinigen Group Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Human Papillomaviru Therapeutics Introduction
13.4.4 Merck Revenue in Human Papillomaviru Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Perrigo Company
13.5.1 Perrigo Company Company Details
13.5.2 Perrigo Company Business Overview
13.5.3 Perrigo Company Human Papillomaviru Therapeutics Introduction
13.5.4 Perrigo Company Revenue in Human Papillomaviru Therapeutics Business (2015-2020)
13.5.5 Perrigo Company Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Human Papillomaviru Therapeutics Introduction
13.6.4 Roche Revenue in Human Papillomaviru Therapeutics Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Bausch Health
13.7.1 Bausch Health Company Details
13.7.2 Bausch Health Business Overview
13.7.3 Bausch Health Human Papillomaviru Therapeutics Introduction
13.7.4 Bausch Health Revenue in Human Papillomaviru Therapeutics Business (2015-2020)
13.7.5 Bausch Health Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Human Papillomaviru Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Human Papillomaviru Therapeutics Revenue
Table 3. Ranking of Global Top Human Papillomaviru Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Human Papillomaviru Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunomodulators
Table 6. Key Players of Keratolytic Agents
Table 7. Key Players of Anti-neoplastic Agents
Table 8. Key Players of Sinecatechins
Table 9. Global Human Papillomaviru Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Human Papillomaviru Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Human Papillomaviru Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Human Papillomaviru Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Human Papillomaviru Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Human Papillomaviru Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Human Papillomaviru Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Human Papillomaviru Therapeutics Players
Table 20. Global Human Papillomaviru Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Human Papillomaviru Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Human Papillomaviru Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomaviru Therapeutics as of 2019)
Table 23. Global Human Papillomaviru Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Human Papillomaviru Therapeutics Product Solution and Service
Table 26. Date of Enter into Human Papillomaviru Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Human Papillomaviru Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Human Papillomaviru Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Human Papillomaviru Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Human Papillomaviru Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Human Papillomaviru Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Human Papillomaviru Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Human Papillomaviru Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Human Papillomaviru Therapeutics Market Share (2019-2020)
Table 36. North America Human Papillomaviru Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Human Papillomaviru Therapeutics Market Share by Type (2015-2020)
Table 38. North America Human Papillomaviru Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Human Papillomaviru Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Human Papillomaviru Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Human Papillomaviru Therapeutics Market Share (2019-2020)
Table 42. Europe Human Papillomaviru Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Human Papillomaviru Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Human Papillomaviru Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Human Papillomaviru Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Human Papillomaviru Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Human Papillomaviru Therapeutics Market Share (2019-2020)
Table 48. China Human Papillomaviru Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Human Papillomaviru Therapeutics Market Share by Type (2015-2020)
Table 50. China Human Papillomaviru Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Human Papillomaviru Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Human Papillomaviru Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Human Papillomaviru Therapeutics Market Share (2019-2020)
Table 54. Japan Human Papillomaviru Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Human Papillomaviru Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Human Papillomaviru Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Human Papillomaviru Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Human Papillomaviru Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Human Papillomaviru Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Human Papillomaviru Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Human Papillomaviru Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Human Papillomaviru Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Human Papillomaviru Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Human Papillomaviru Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Human Papillomaviru Therapeutics Market Share (2019-2020)
Table 66. India Human Papillomaviru Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Human Papillomaviru Therapeutics Market Share by Type (2015-2020)
Table 68. India Human Papillomaviru Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Human Papillomaviru Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Human Papillomaviru Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Human Papillomaviru Therapeutics Market Share (2019-2020)
Table 72. Central & South America Human Papillomaviru Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Human Papillomaviru Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Human Papillomaviru Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Human Papillomaviru Therapeutics Market Share by Application (2015-2020)
Table 76. AbbVie Company Details
Table 77. AbbVie Business Overview
Table 78. AbbVie Product
Table 79. AbbVie Revenue in Human Papillomaviru Therapeutics Business (2015-2020) (Million US$)
Table 80. AbbVie Recent Development
Table 81. Actavis Company Details
Table 82. Actavis Business Overview
Table 83. Actavis Product
Table 84. Actavis Revenue in Human Papillomaviru Therapeutics Business (2015-2020) (Million US$)
Table 85. Actavis Recent Development
Table 86. Clinigen Group Company Details
Table 87. Clinigen Group Business Overview
Table 88. Clinigen Group Product
Table 89. Clinigen Group Revenue in Human Papillomaviru Therapeutics Business (2015-2020) (Million US$)
Table 90. Clinigen Group Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Product
Table 94. Merck Revenue in Human Papillomaviru Therapeutics Business (2015-2020) (Million US$)
Table 95. Merck Recent Development
Table 96. Perrigo Company Company Details
Table 97. Perrigo Company Business Overview
Table 98. Perrigo Company Product
Table 99. Perrigo Company Revenue in Human Papillomaviru Therapeutics Business (2015-2020) (Million US$)
Table 100. Perrigo Company Recent Development
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Product
Table 104. Roche Revenue in Human Papillomaviru Therapeutics Business (2015-2020) (Million US$)
Table 105. Roche Recent Development
Table 106. Bausch Health Company Details
Table 107. Bausch Health Business Overview
Table 108. Bausch Health Product
Table 109. Bausch Health Revenue in Human Papillomaviru Therapeutics Business (2015-2020) (Million US$)
Table 110. Bausch Health Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Papillomaviru Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Immunomodulators Features
Figure 3. Keratolytic Agents Features
Figure 4. Anti-neoplastic Agents Features
Figure 5. Sinecatechins Features
Figure 6. Global Human Papillomaviru Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Genital Warts Case Studies
Figure 8. Genital Cancer Case Studies
Figure 9. Epidermodysplasia Verruciformis Case Studies
Figure 10. Oral Papillomas Case Studies
Figure 11. Oropharyngeal Cancer Case Studies
Figure 12. Laryngeal Papillomatosis Case Studies
Figure 13. Others Case Studies
Figure 14. Human Papillomaviru Therapeutics Report Years Considered
Figure 15. Global Human Papillomaviru Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Human Papillomaviru Therapeutics Market Share by Regions: 2020 VS 2026
Figure 17. Global Human Papillomaviru Therapeutics Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Human Papillomaviru Therapeutics Market Share by Players in 2019
Figure 20. Global Top Human Papillomaviru Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomaviru Therapeutics as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Human Papillomaviru Therapeutics Revenue in 2019
Figure 22. North America Human Papillomaviru Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Human Papillomaviru Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Human Papillomaviru Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Human Papillomaviru Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Human Papillomaviru Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Human Papillomaviru Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Human Papillomaviru Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed